Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer

Clinical trial NCT00055692 · COMPLETED

Trial details

NCT number: NCT00055692
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Primary Hepatocellular Carcinoma Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer

Start date: 2003-02-01
Primary completion: 2008-01-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.